Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Aine Carol Burke, Ronan T Swords, Kevin Kelly & Francis J Giles. (2011) Current status of agents active against the T315I chronic myeloid leukemia phenotype. Expert Opinion on Emerging Drugs 16:1, pages 85-103.
Read now
Read now
Amanda J. Redig, Eliza Vakana & Leonidas C. Platanias. (2011) Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR–ABL. Leukemia & Lymphoma 52:sup1, pages 45-53.
Read now
Read now
Jennifer S Carew, Steffan T Nawrocki, Francis J Giles & John L Cleveland. (2008) Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance. Biologics: Targets and Therapy 2:2, pages 201-204.
Read now
Read now
Roberto R Rosato & Steven Grant. (2005) Histone deacetylase inhibitors: insights into mechanisms of lethality. Expert Opinion on Therapeutic Targets 9:4, pages 809-824.
Read now
Read now
Articles from other publishers (65)
Christophe Blanquart. 2023. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
507
538
.
Gheath Alatrash, Chantal Saberian, Roland Bassett, Peter F. Thall, Celina Ledesma, Yoshimi Lu, May Daher, Benigno C. Valdez, Jitesh Kawedia, Uday Popat, Rohtesh Mehta, Betul Oran, Yago Nieto, Amanda Olson, Paolo Anderlini, David Marin, Chitra Hosing, Amin M. Alousi, Elizabeth J. Shpall, Gabriela Rondon, Julianne Chen, Muzaffar Qazilbash, Richard E. Champlin & Partow Kebriaei. (2022) Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes. Transplantation and Cellular Therapy 28:8, pages 501.e1-501.e7.
Crossref
Crossref
Ali Salimi-Jeda, Soad Ghabeshi, Zeinab Gol Mohammad pour, Ehsan Ollah Jazaeri, Mehrdad Araiinejad, Farzaneh Sheikholeslami, Mohsen Abdoli, Mahdi Edalat & Asghar Abdoli. (2022) Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy. Cancer Treatment and Research Communications 30, pages 100512.
Crossref
Crossref
Rachel E. Carlisle, Salwa Farooqi, Ming Chan Zhang, Sarah Liu, Chao Lu, Andy Phan, Elise Brimble & Jeffrey G. Dickhout. (2021) Inhibition of histone deacetylation with vorinostat does not prevent tunicamycin-mediated acute kidney injury. PLOS ONE 16:11, pages e0260519.
Crossref
Crossref
Christophe Blanquart, Camille Linot, Pierre-François Cartron, Daniela Tomaselli, Antonello Mai & Philippe Bertrand. (2019) Epigenetic Metalloenzymes. Current Medicinal Chemistry 26:15, pages 2748-2785.
Crossref
Crossref
Shinichi Namba, Rei Nakano, Taku Kitanaka, Nanako Kitanaka, Tomohiro Nakayama & Hiroshi Sugiya. (2017) ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts. PLOS ONE 12:8, pages e0182923.
Crossref
Crossref
Jianzhong Ye, Wenrui Wu, Yating Li & Lanjuan Li. (2017) Influences of the Gut Microbiota on DNA Methylation and Histone Modification. Digestive Diseases and Sciences 62:5, pages 1155-1164.
Crossref
Crossref
Taku Kitanaka, Rei Nakano, Nanako Kitanaka, Taro Kimura, Ken Okabayashi, Takanori Narita & Hiroshi Sugiya. (2017) JNK activation is essential for activation of MEK/ERK signaling in IL-1β-induced COX-2 expression in synovial fibroblasts. Scientific Reports 7:1.
Crossref
Crossref
Qin Qin, Hongyan Cheng, Jing Lu, Liangliang Zhan, Jianchao Zheng, Jing Cai, Xi Yang, Liping Xu, Hongcheng Zhu, Chi Zhang, Jia Liu, Jianxin Ma, Xizhi Zhang, Shengbin Dai & Xinchen Sun. (2014) Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair. Journal of Hematology & Oncology 7:1.
Crossref
Crossref
S L Locatelli, L Cleris, G G Stirparo, S Tartari, E Saba, M Pierdominici, W Malorni, A Carbone, A Anichini & C Carlo-Stella. (2014) BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts. Leukemia 28:9, pages 1861-1871.
Crossref
Crossref
Mohamed-Salah Abaza, Abdul-Majeed Bahman & Raja'a Al-Attiyah. (2014) Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: Underlying molecular mechanisms. International Journal of Molecular Medicine.
Crossref
Crossref
F Ye, Z Yang, Y Liu, D Gong, T Ji, J Wang, B Xi, J Zhou, D Ma & Q Gao. (2014) Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation. Cancer Gene Therapy 21:5, pages 209-217.
Crossref
Crossref
Satoshi Ichikawa, Nana Tatebayashi & Akira Matsuda. (2013)
Synthesis of
C
-Glycosyl Pyrrolo[3,4-
c
]carbazole-1,3(2
H
,6
H
)-diones as a Scaffold for Check Point Kinase 1 Inhibitors
. The Journal of Organic Chemistry 78:23, pages 12065-12075.
Crossref
Crossref
Hui Zhang, Shotaro Nakajima, Hironori Kato, Liubao Gu, Tatsuya Yoshitomi, Kaoru Nagai, Hideyuki Shinmori, Susumu Kokubo & Masanori Kitamura. (2013) Selective, potent blockade of the IRE1 and ATF6 pathways by 4-phenylbutyric acid analogues. British Journal of Pharmacology 170:4, pages 822-834.
Crossref
Crossref
Takashi Seto, Taito Esaki, Fumihiko Hirai, Shuji Arita, Kaname Nosaki, Akitaka Makiyama, Takuro Kometani, Chinatsu Fujimoto, Motoharu Hamatake, Hiroaki Takeoka, Felix Agbo & Xiaojin Shi. (2013) Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours. Cancer Chemotherapy and Pharmacology 72:3, pages 619-627.
Crossref
Crossref
Fangfang Wang, Zhi Ma, Yan Li, Jinan Wang & Yonghua Wang. (2012) Structural requirements of pyrimidine, thienopyridine and ureido thiophene carboxamide-based inhibitors of the checkpoint kinase 1: QSAR, docking, molecular dynamics analysis. Journal of Molecular Modeling 18:7, pages 3227-3242.
Crossref
Crossref
Vibha Oza, Susan Ashwell, Lynsie Almeida, Patrick Brassil, Jason Breed, Chun Deng, Thomas Gero, Michael Grondine, Candice Horn, Stephanos Ioannidis, Dongfang Liu, Paul Lyne, Nicholas Newcombe, Martin Pass, Jon Read, Shannon Ready, Siân Rowsell, Mei Su, Dorin Toader, Melissa Vasbinder, Dingwei Yu, Yan Yu, Yafeng Xue, Sonya Zabludoff & James Janetka. (2012)
Discovery of Checkpoint Kinase Inhibitor (
S
)-5-(3-Fluorophenyl)-
N
-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas
. Journal of Medicinal Chemistry 55:11, pages 5130-5142.
Crossref
Crossref
M Bartucci, S Svensson, P Romania, R Dattilo, M Patrizii, M Signore, S Navarra, F Lotti, M Biffoni, E Pilozzi, E Duranti, S Martinelli, C Rinaldo, A Zeuner, M Maugeri-Saccà, A Eramo & R De Maria. (2011) Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death & Differentiation 19:5, pages 768-778.
Crossref
Crossref
Vadim Y. Dudkin, Keith Rickert, Constantine Kreatsoulas, Cheng Wang, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Yowei Yan, Mari Ikuta, Steven M. Stirdivant, Robert A. Drakas, Eileen S. Walsh, Kelly Hamilton, Carolyn A. Buser, Robert B. Lobell & Laura Sepp-Lorenzino. (2012) Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates. Bioorganic & Medicinal Chemistry Letters 22:7, pages 2609-2612.
Crossref
Crossref
Robert W. Robey, Arup R. Chakraborty, Agnes Basseville, Victoria Luchenko, Julian Bahr, Zhirong Zhan & Susan E. Bates. (2011) Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance. Molecular Pharmaceutics 8:6, pages 2021-2031.
Crossref
Crossref
Hidemi Rikiishi. (2011) Autophagic and Apoptotic Effects of HDAC Inhibitors on Cancer Cells. Journal of Biomedicine and Biotechnology 2011, pages 1-9.
Crossref
Crossref
Peter W. Atadja. 2011. Epigenetics and Disease. Epigenetics and Disease
175
195
.
Kamil Gotfryd, Galina Skladchikova, Eugene A Lepekhin, Vladimir Berezin, Elisabeth Bock & Peter S Walmod. (2010) Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation. BMC Cancer 10:1.
Crossref
Crossref
Masahiro Yoshikawa, Keiichi Hishikawa, Mana Idei & Toshiro Fujita. (2010) Trichostatin a prevents TGF-β1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. European Journal of Pharmacology 642:1-3, pages 28-36.
Crossref
Crossref
Crispin R. DassMei Lin TanStuart J. GallowayPeter F.M. Choong. (2010) Dz13 Induces a Cytotoxic Stress Response with Upregulation of E2F1 in Tumor Cells Metastasizing to or from Bone. Oligonucleotides 20:2, pages 79-91.
Crossref
Crossref
V. Raja Solomon & Hoyun Lee. (2009) Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies. European Journal of Pharmacology 625:1-3, pages 220-233.
Crossref
Crossref
Teneille Walker, Clint Mitchell, Margaret A. Park, Adly Yacoub, Martin Graf, Mohamed Rahmani, Peter J. Houghton, Christina Voelkel-Johnson, Steven Grant & Paul Dent. (2009) Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms. Molecular Pharmacology 76:2, pages 342-355.
Crossref
Crossref
Q-L Zhang, L Wang, Y-W Zhang, X-X Jiang, F Yang, W-L Wu, A Janin, Z Chen, Z-X Shen, S-J Chen & W-L Zhao. (2009) The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis. Leukemia 23:8, pages 1507-1514.
Crossref
Crossref
Manuela Mancini, Nevena Veljkovic, Valentina Corradi, Elisa Zuffa, Patrizia Corrado, Eleonora Pagnotta, Giovanni Martinelli, Enza Barbieri & Maria Alessandra Santucci. (2009) 14-3-3 Ligand Prevents Nuclear Import of c-ABL Protein in Chronic Myeloid Leukemia. Traffic 10:6, pages 637-647.
Crossref
Crossref
Jin-Ping Lai, Dalbir S. Sandhu, Catherine D. Moser, Sophie C. Cazanave, Abdul M. Oseini, Abdirashid M. Shire, Viji Shridhar, Schuyler O. Sanderson & Lewis R. Roberts. (2009) Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. Journal of Hepatology 50:6, pages 1112-1121.
Crossref
Crossref
K R Greenow, A R Clarke & R H Jones. (2009) Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation. Oncogene 28:11, pages 1443-1453.
Crossref
Crossref
Guo Zhang, Margaret A. Park, Clint Mitchell, Hossein Hamed, Mohamed Rahmani, Aditi Pandya Martin, David T. Curiel, Adly Yacoub, Martin Graf, Ray Lee, John D. Roberts, Paul B. Fisher, Steven Grant & Paul Dent. (2008) Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation. Clinical Cancer Research 14:17, pages 5385-5399.
Crossref
Crossref
Kazuo Kamemura, Akihiro Ito, Tadahiro Shimazu, Akihisa Matsuyama, Satoko Maeda, Tso-Pang Yao, Sueharu Horinouchi, Saadi Khochbin & Minoru Yoshida. (2008) Effects of downregulated HDAC6 expression on the proliferation of lung cancer cells. Biochemical and Biophysical Research Communications 374:1, pages 84-89.
Crossref
Crossref
Ching-Tai Lin, Hung-Cheng Lai, Hsin-Yi Lee, Wei-Hsin Lin, Cheng-Chang Chang, Tang-Yuan Chu, Ya-Wen Lin, Kuan-Der Lee & Mu-Hsien Yu. (2008) Valproic acid resensitizes cisplatin-resistant ovarian cancer cells. Cancer Science 99:6, pages 1218-1226.
Crossref
Crossref
Guillermo Garcia-Manero, Hui Yang, Carlos Bueso-Ramos, Alessandra Ferrajoli, Jorge Cortes, William G. Wierda, Stefan Faderl, Charles Koller, Gail Morris, Gary Rosner, Andrey Loboda, Valeria R. Fantin, Sophia S. Randolph, James S. Hardwick, John F. Reilly, Cong Chen, Justin L. Ricker, J. Paul Secrist, Victoria M. Richon, Stanley R. Frankel & Hagop M. Kantarjian. (2008) Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood 111:3, pages 1060-1066.
Crossref
Crossref
N Bucher & C D Britten. (2008) G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. British Journal of Cancer 98:3, pages 523-528.
Crossref
Crossref
Roberto R. Rosato & Steven Grant. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
115
131
.
Valeria R. Fantin & Victoria M. Richon. (2007) Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications. Clinical Cancer Research 13:24, pages 7237-7242.
Crossref
Crossref
Zhi-Fu Tao, Zehan Chen, Mai-Ha Bui, Peter Kovar, Eric Johnson, Jennifer Bouska, Haiying Zhang, Saul Rosenberg, Thomas Sowin & Nan-Horng Lin. (2007) Macrocyclic ureas as potent and selective Chk1 inhibitors: An improved synthesis, kinome profiling, structure–activity relationships, and preliminary pharmacokinetics. Bioorganic & Medicinal Chemistry Letters 17:23, pages 6593-6601.
Crossref
Crossref
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, Kent D. Stewart, Zehan Chen, Mai-Ha Bui, Philip Merta, Chang Park, Peter Kovar, Haiying Zhang, Hing L. Sham, Saul H. Rosenberg, Thomas J. Sowin & Nan-Horng Lin. (2007) Discovery of 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2′-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors. Bioorganic & Medicinal Chemistry Letters 17:21, pages 5944-5951.
Crossref
Crossref
Hiroshi Nakanishi, Tatsuya Nakamura, Eli Canaani & Carlo M. Croce. (2007)
ALL1 fusion proteins induce deregulation of
EphA7
and ERK phosphorylation in human acute leukemias
. Proceedings of the National Academy of Sciences 104:36, pages 14442-14447.
Crossref
Crossref
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, Zehan Chen, Philip Merta, Peter Kovar, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham, Thomas J. Sowin & Nan-Horng Lin. (2007) Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors. Bioorganic & Medicinal Chemistry Letters 17:15, pages 4308-4315.
Crossref
Crossref
Jennifer S. Carew, Steffan T. NawrockiCharissa N. KahueHui Zhang, Chunying Yang, Linda Chung, Janet A. HoughtonPeng Huang, Francis J. GilesJohn L. Cleveland. (2007) Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance. Blood 110:1, pages 313-322.
Crossref
Crossref
Jun Shen, Canhua Huang, Lu Jiang, Feng Gao, Zhi Wang, Yuanyuan Zhang, Jingping Bai, Hongmei Zhou & Qianming Chen. (2007) Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines. Biochemical Pharmacology 73:12, pages 1901-1909.
Crossref
Crossref
Yunsong Tong, Akiyo Claiborne, Kent D. Stewart, Chang Park, Peter Kovar, Zehan Chen, Robert B. Credo, Wen-Zhen Gu, Stephen L. GwaltneyIIII, Russell A. Judge, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham, Thomas J. Sowin & Nan-horng Lin. (2007) Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors. Bioorganic & Medicinal Chemistry 15:7, pages 2759-2767.
Crossref
Crossref
Rainer Kuefer, Felicitas Genze, Waltraud Zugmaier, Richard E. Hautmann, Ludwig Rinnab, Juergen E. Gschwend, Marina Angelmeier, Aidee Estrada & Berthold Buechele. (2007) Antagonistic Effects of Sodium Butyrate and N-(4-Hydroxyphenyl)-retinamide on Prostate Cancer. Neoplasia 9:3, pages 246-253.
Crossref
Crossref
Zehan Chen, Zhan Xiao, Wen-zhen Gu, John Xue, Mai H. Bui, Peter Kovar, Gaoquan Li, Gary Wang, Zhi-Fu Tao, Yunsong Tong, Nan-Horng Lin, Hing L. Sham, Jean Y. J. Wang, Thomas J. Sowin, Saul H. Rosenberg & Haiying Zhang. (2006) Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics. International Journal of Cancer 119:12, pages 2784-2794.
Crossref
Crossref
Paul A. Marks. (2006) Thioredoxin in cancer—Role of histone deacetylase inhibitors. Seminars in Cancer Biology 16:6, pages 436-443.
Crossref
Crossref
Massimo Ammirante, Rita Di Giacomo, Laura De Martino, Alessandra Rosati, Michela Festa, Antonio Gentilella, Maria Carmela Pascale, Maria Antonietta Belisario, Arturo Leone, Maria Caterina Turco & Vincenzo De Feo. (2006) 1-Methoxy-Canthin-6-One Induces c-Jun NH2-Terminal Kinase–Dependent Apoptosis and Synergizes with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Activity in Human Neoplastic Cells of Hematopoietic or Endodermal Origin. Cancer Research 66:8, pages 4385-4393.
Crossref
Crossref
R Abdul-Ghani, V Serra, B Györffy, K Jürchott, A Solf, M Dietel & R Schäfer. (2005) The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 25:12, pages 1743-1752.
Crossref
Crossref
Jorge Cortes. (2006) Overcoming drug resistance in chronic myeloid leukemia. Current Opinion in Hematology 13:2, pages 79-86.
Crossref
Crossref
Gianluca Brusa, Elisa Zuffa, Manuela Mancini, Michela Benvenuti, Natalia Calonghi, Enza Barbieri & Maria Alessandra Santucci. (2005) P210 Bcr‐abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors. British Journal of Haematology 132:3, pages 359-369.
Crossref
Crossref
Ning GaoMohamed RahmaniXianglin ShiPaul DentSteven Grant. (2006) Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress. Blood 107:1, pages 241-249.
Crossref
Crossref
Nan-Horng Lin, Ping Xia, Peter Kovar, Chang Park, Zehan Chen, Haiying Zhang, Saul H. Rosenberg & Hing L. Sham. (2006) Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors. Bioorganic & Medicinal Chemistry Letters 16:2, pages 421-426.
Crossref
Crossref
Milin R. Acharya, Alex Sparreboom, Jürgen Venitz & William D. Figg. (2005) Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review. Molecular Pharmacology 68:4, pages 917-932.
Crossref
Crossref
C Yu, G Dasmahapatra, P Dent & S Grant. (2005) Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells. Leukemia 19:9, pages 1579-1589.
Crossref
Crossref
Zhan Xiao, John Xue, Dimitri Semizarov, Thomas J. Sowin, Saul H. Rosenberg & Haiying Zhang. (2005) Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics. International Journal of Cancer 115:4, pages 528-538.
Crossref
Crossref
Deepa B. Shankar, Jerry C. Cheng, Kentaro Kinjo, Noah Federman, Theodore B. Moore, Amandip Gill, Nagesh P. Rao, Elliot M. Landaw & Kathleen M. Sakamoto. (2005) The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7:4, pages 351-362.
Crossref
Crossref
Mohamed Rahmani, Erin Reese, Yun Dai, Cheryl Bauer, Shawn G. Payne, Paul Dent, Sarah Spiegel & Steven Grant. (2005) Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species. Cancer Research 65:6, pages 2422-2432.
Crossref
Crossref
J. S. Ungerstedt, Y. Sowa, W.-S. Xu, Y. Shao, M. Dokmanovic, G. Perez, L. Ngo, A. Holmgren, X. Jiang & P. A. Marks. (2005) Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proceedings of the National Academy of Sciences 102:3, pages 673-678.
Crossref
Crossref
Omar Eton. 2005.
739
748
.
S Grant. (2004) The novel histone deacetylase inhibitor NVP-LAQ824: an addition to the therapeutic armamentarium in leukemia?. Leukemia 18:12, pages 1931-1933.
Crossref
Crossref
Ning Gao, Yun Dai, Mohamed Rahmani, Paul Dent & Steven Grant. (2004) Contribution of Disruption of the Nuclear Factor-κB Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol. Molecular Pharmacology 66:4, pages 956-963.
Crossref
Crossref
R Tang, A-M Faussat, P Majdak, J-Y Perrot, D Chaoui, O Legrand & J-P Marie. (2004) Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. Leukemia 18:7, pages 1246-1251.
Crossref
Crossref
Antonio Valencia & Julio Morán. (2004) Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radical Biology and Medicine 36:9, pages 1112-1125.
Crossref
Crossref